IMU 5.26% 5.4¢ imugene limited

Gossip was wrong. Looks like he achieved something...

  1. 12,277 Posts.
    lightbulb Created with Sketch. 3753
    Gossip was wrong. Looks like he achieved something positive.

    Diagnostics specialist Lantheus, capitalised at $8 billion on the Nasdaq, likes the look of Aussie Radiopharm Theranostics.
    Street Talk understands Lantheus has agreed to pay a 47 per cent premium to Radiopharm’s last close to come in as a cornerstone investor on an equity raise of up to $65 million. It will tip in $US7 million at 5¢ a share, with the option to top up by another $US5 million. Price at posting: 3.
    Diagnostics specialist Lantheus, capitalised at $8 billion on the Nasdaq, likes the look of Aussie Radiopharm Theranostics.
    Street Talk understands Lantheus has agreed to pay a 47 per cent premium to Radiopharm’s last close to come in as a cornerstone investor on an equity raise of up to $65 million. It will tip in $US7 million at 5¢ a share, with the option to top up by another $US5 million.

    Should that be right, then he might have change his reputation from "Mr Huge Discount" to "Mr Huge Premium".

    Anyway, he is still good to keep ones blood pressure at a high, LOL

    GLTA
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.4¢
Change
-0.003(5.26%)
Mkt cap ! $395.2M
Open High Low Value Volume
5.5¢ 5.7¢ 5.4¢ $1.444M 26.24M

Buyers (Bids)

No. Vol. Price($)
24 3824179 5.4¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 172983 1
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.